Marketing submits already rejected claims.
Colombia-first validation
Regulatory compliance and speed are not opposites.
MLR platform for Regulatory, Medical and Compliance teams in LATAM pharma.
MLR-specific Colombia first No patient data Waitlist open
Version v4 in review
Claim review
Promotional material, cardiology Q3
Claim needs an approved reference before signature.
Review path
Medical
Approved
Legal
With notes
Regulatory
In review
3
roles
1
audit trail
Scan
planned
Built around the regulatory flows of
INVIMA ANVISA COFEPRIS ANMAT ICA 21 CFR Part 11
Problem
If your MLR team works like this, ReviuFlow is for you.
Not a people problem, an infrastructure problem to review, trace and defend decisions.
Every version is reviewed from zero.
History gets reconstructed from email.
Criteria live in one person's head.
Events and launches slip late.
Solution
How ReviuFlow works.
Review path
- 2 h
Medical
Approved
- 1 d
Legal
With notes
- Now
Regulatory
In review
MLR workflow
Medical, Legal and Regulatory paths with owners, status and role-based SLAs.
Audit trail
- 09:42
Regulatory
Reference requested
- 10:14
Medical
Approved with notes
- 11:02
Legal
Electronic signature
- 11:03
System
Audit trail sealed
Traceability
Versions, comments and approvals in one exportable evidence trail.
Scan
- high
Claim without anchored reference.
- medium
Indication outside approved label.
- low
Adverse event disclaimer missing.
View suggestions
Scan
Planned pre-check to flag risks before formal review.
What a review looks like
Three steps, continuous evidence.
- 01
Upload the material
PDF, deck or claim sheet with metadata and review path.
- 02
Review only what changed
Visual diff and inline comments per version.
- 03
Export evidence
Audit trail, approvals and signature ready for audit.
Differentiation
MLR-specific, not generic workflow.
What you use today
Gaps-
Email, Word and Drive
Defensible traceability
-
SharePoint + Power Automate
MLR criteria and claims
-
Veeva PromoMats
Mid-market accessibility
ReviuFlow
Answer-
Audit trail and versions
-
Workflow designed for pharma
-
Focused implementation and reachable pricing
Teams
Built for the teams carrying regulatory responsibility.
Regulatory
- Approval history
- Traceable claims
- Audit-ready evidence
Medical
Clinical champion
- Connected references
- Version-level comments
- Less manual revalidation
IT and security
- SSO planned
- US or EU hosting
- Customer isolation
Compliance and security
Rigor visible from the architecture.
Controls that Compliance and IT can evaluate from day one.
Multi-tenant with customer isolation.
Encryption at rest and in transit.
Product principle
Immutable audit trail as a product principle.
Every action, version and approval is sealed the moment it happens. Evidence is not rewritten, it is exported.
Electronic signature with 21 CFR Part 11 equivalence.
SSO with Auth0 or Clerk.
Roadmap to SOC 2 Type II.
Founding members
Founding members
The first teams in the waitlist co-design the product and access founding terms.
- 01
Founding price for qualified early adopters.
- 02
Assisted migration of recent history.
- 03
Monthly sessions with the founding team.
/ 04
Target guarantee: 50% shorter MLR cycle in 90 days.
FAQ
Frequently asked questions
What is MLR?
Medical, Legal, Regulatory: the review process for promotional materials, scientific content and claims before use.
Is ReviuFlow available today?
It is in validation. The waitlist helps us prioritize conversations with real teams before the MVP.
Why Colombia first?
Focus, local language and INVIMA context. The thesis is still LATAM.
Do you process patient data?
No. The platform focuses on promotional, scientific and regulatory materials.
Do you publish pricing?
Not in V1. Each proposal depends on reviewers, countries, volume and scope.
What happens after the waitlist?
You will receive updates and, if your profile fits ICP V1, we may invite you to discovery.
Open validation
Help us validate whether ReviuFlow should exist.
If your team runs MLR through email, Word and shared folders, we want to learn from your case.
Early access
Join the waitlist
Tell us who you are and how your team handles MLR reviews today.